Chrousos Phaedra 4
4 · Vanda Pharmaceuticals Inc. · Filed Jun 14, 2021
Insider Transaction Report
Form 4
Chrousos Phaedra
Director
Transactions
- Award
Common Stock
2021-06-10+5,000→ 15,000 total - Award
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 totalExercise: $19.21Exp: 2031-06-09→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.